MSP involves treatment of genomic DNA with sodium bisulfite, which converts unmethylated cytosine residues to uracil, while methylated cytosines remain unchanged. Specific primers are then used to amplify either methylated or unmethylated DNA, allowing for the detection of methylation status.
